FAQ
Consultation
Testimonials
Order
TCM basis
Contact Us
Papers & Reports

 

Case Study--Canelim Capsules combined with radiotherapy in treating Esophageal Cancer

Zhang L. Zheng, et al. NingXia Medical University

Result:

Table 1--Effectiveness

Croup
Cases
CR
PR
SD
PD
Total Effective % (CR+PR)
Canelim
34
20
8
6
0
82.35*
Control
34
15
5
9
5
58.82

Table 2--Hemogram

Group
Cases
WBC lowered
HGB Lowered
PLT lowered
<4*10^9/L
<9g/L
< 0.9*10^9/L
Canelim
34
4 (11.76%)**
1 (2.94%)
2 (5.88%)
Control
34
16 (47.71%)
4 (11.76%)
5 (14.71%)
compared with control group, * means p<0.05, ** means p<0.01

Table 3--Immunity changes

Immunity
Before ()
After ()
P
Lymphocyt proliferation rate
51.13 13.80
67.25 10
<0.05
T cell sub-group
T3
51.23 13.50
52.31 14.45
>0.05
T4
30.64 10.03
33.21 11.07
>0.05
T8
27.01 6.01
23.25 8.78
>0.05
T4/T8
1.13 0.25
1.57 0.78
>0.05

Treatment methods:
Control Group:
radiotherapy, Dt70 Gy 35 times in7 weeks
Canelim Group: Canelim Capsules, 4*3 times/day, combined with above chemotherapy treatment

Discuss:

Table 1--Effectiveness: The total effective rate in Canleim group (82.35%) is much higher than that in chemotherapy control group (p<0.05).
Table 2--Hemogram: The hemogram shows: the main side effect of radiotherapy, bone marrow inhibition, is partially relieved by Canelim Capsules.
Table 3--Immunity Changes: The lymphocyt proliferation rate arises, T3 & T4 keeps stable, while inhibitive T8 decreases. All of these indicate that Canelim Capsules can protect the immune function of patients under radiotherapy.

Conclusion:
When combined with radiotherapy, Canelim capsules can not only kill cancer cells, shrink the the tumor, ameliorate symptoms, and also protect blood cells and immunity from radiation injury.


 

E-mail